Panama City, Panama
July 16 - July 18, 2009

This two day event will be centered on GH deficiency in childhood, adolescence and adulthood where the best tools to diagnose these disorders, how to follow-up the patients’ transition from adolescence to adulthood and the optimal treating strategies will be discussed. Futhermore, the detrimental long term effects of GH deficiency on cardiovascular and metabolic health and the role of GH therapy in ameliorating these effects will be also critically reviewed as well as the transition from adolescence to adulthood in girls with Turner syndrome and the evaluation of the role of GH and estrogens in post puberty.

LEARNING OBJECTIVES

Attending this symposium, participants will achieve an up-to-date knowledge on:

• Best available tool aimed to diagnose and treat GH deficiency during childhood and adolescence;
• The importance of re-evaluating the GH status of adolescents at final height;
• Patients selection for GH treatment in adulthood;
• Evaluation of the role of GH, IGF1 and sex steroids on the metabolic regulation at puberty;
• Deleterious effects of GH deficiency on the cardiovascular and metabolic status and the beneficial role of GH treatment;
• To define the best ways or options to complete the transition from the pediatric clinic to the adult clinic

TARGET AUDIENCE

Pediatric and adult endocrinologists.